Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past?

Tuesday, May 12, 2020 - 12:31 in Biology & Nature

CanSino Biologics, Johnson & Johnson, and the University of Oxford are all using genetically engineered common cold viruses to make COVID-19 vaccines. The technology is more than 30 years in the making, but it's yet to yield an effective vaccine for humans

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net